CCL2: a Chemokine Potentially Promoting Early Seeding of the Latent HIV Reservoir

Author:

Packard Thomas A.1,Schwarzer Roland12,Herzig Eytan1,Rao Deepashri3,Luo Xiaoyu1,Egedal Johanne H.1,Hsiao Feng1,Widera Marek4,Hultquist Judd F.156,Grimmett Zachary W.1,Messer Ronald J.3,Krogan Nevan J.156,Deeks Steven G.7,Roan Nadia R.18,Dittmer Ulf24,Hasenkrug Kim J.3ORCID,Greene Warner C.179ORCID

Affiliation:

1. J. David Gladstone Institutes, San Francisco, California, USA

2. Institute for Translational HIV Research, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

3. Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA

4. Institute for Virology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

5. Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, California, USA

6. Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, USA

7. Department of Medicine, University of California San Francisco, San Francisco, California, USA

8. Department of Urology, University of California San Francisco, San Francisco, California, USA

9. Department of Microbiology and Immunology, University of California San Francisco, San Francisco, California, USA

Abstract

There are currently over 35 million people living with HIV worldwide, and we still have no vaccine or scalable cure. One of the difficulties with HIV is its ability to rapidly establish a viral reservoir in lymphoid tissues that allows it to elude antivirals and the immune system.

Funder

HHS | NIH | National Institute of Allergy and Infectious Diseases

Foundation for the National Institutes of Health

Deutsche Forschungsgemeinschaft

James B. Pendleton Charitable Trust

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3